Mettler-Toledo International Inc.
NYSE:MTDMedical - Diagnostics & Research
+$16.60 today
- Market cap
- $34.55B
- Beta
- 1.26
- P/E (TTM)
- 26.6
- EPS (TTM)
- $43.14
Volume 0.16M
Average 0.19M
MTD EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Mettler-Toledo International Inc.NYSE: MTD
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $347.2M rose 17.3% year over year, ahead of the +7.1% change in trailing-twelve-month EBITDA. Sequentially, it rose 33.9% from the prior quarter. Over 3 fiscal years it compounded at +0.1% a year.
Context
- EBITDA amounted to 30.9% of revenue in FY2025, down 1.4 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 9 analysts of $1.4B (+13.0%) for the fiscal year ending Dec 2026, a step up from the -0.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $347.2M+33.9% QoQ
- Last fiscal yearDec 2025
- $1.24B-0.6% YoY
- LTMJun 2026
- $1.31B+7.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +17.3% | +6.8% | -10.5 pp |
| 1 year | -0.6% | +13.0% | +13.5 pp |
| 3-year CAGR | +0.1% | +10.5% | +10.4 pp |
| 5-year CAGR | +10.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 1.24B USD
- Year-over-year change
- -0.6%
- 4-year CAGR
- +3.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.24B | -0.6% |
| FY2024 | 2024-12-31 | 1.25B | +4.1% |
| FY2023 | 2023-12-31 | 1.2B | -3.1% |
| FY2022 | 2022-12-31 | 1.24B | +12.4% |
| FY2021 | 2021-12-31 | 1.1B | — |
EBITDA vs competitors
How MTD compares with its peers on the latest reported figures
- MTD's LTM Jun 2026 EBITDA of $1.31B is the 5th highest of the 10 companies compared; the peer median is $957.8M.
- Its year-over-year change of +7.1% is the 4th highest of 10, against a peer median of +0.7%.
- EBITDA amounts to 31.6% of revenue for MTD, versus a peer median of 25.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $11.24B | -0.8% | -1.3% | 23.7% | |
| LTM Sep 2026 | $7.09B | +3.2% | -9.9% | 27.7% | |
| LTM Jul 2026 | $2.04B | +13.2% | -1.2% | 27.6% | |
| LTM Sep 2026 | $1.65B | +18.0% | +3.9% | 25.3% | |
| LTM Jun 2026 | $1.31B | +7.1% | +0.1% | 31.6% | |
| LTM Jun 2026 | $957.8M | +12.1% | -0.2% | 26.7% | |
| LTM Jul 2026 | $950.77M | -10.1% | -0.2% | 20.5% | |
| LTM Jul 2026 | $767M | -6.7% | -13.5% | 26.3% | |
| LTM Jun 2026 | $247.7M | -38.6% | -16.4% | 7.1% | |
| LTM Oct 2026 | $158.84M | +0.7% | -1.6% | 14.6% | |
| Peer median (excluding MTD) | $957.8M | +0.7% | -1.3% | 25.3% | |
Competitors are the stored peer set for MTD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.72B | 3.92B | 3.79B | 3.87B | 4.03B |
| Cost of Revenue | 1.61B | 1.68B | 1.62B | 1.62B | 1.64B |
| Gross Profit | 2.11B | 2.24B | 2.17B | 2.25B | 2.39B |
| Gross Margin | 56.7% | 57.2% | 57.3% | 58.2% | 59.4% |
| Research & Development | 169.77M | 177.12M | 185.28M | 189.36M | 199.37M |
| Selling, General & Admin | 943.98M | 938.46M | 904.11M | 936.3M | 998.31M |
| Operating Expenses | 1.11B | 1.12B | 1.09B | 1.13B | 1.27B |
| Depreciation & Amortization | 108.06M | 113.02M | 121.16M | 123.22M | 125.61M |
| EBITDA | 1.1B | 1.24B | 1.2B | 1.25B | 1.24B |
| EBITDA Margin | 29.7% | 31.6% | 31.7% | 32.3% | 30.9% |
| Operating Income | 994.74M | 1.13B | 1.08B | 1.13B | 1.12B |
| Operating Margin | 26.8% | 28.7% | 28.5% | 29.1% | 27.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 43.24M | 55.39M | 77.37M | 74.63M | 68.52M |
| Other Income / Expenses | (45.38M) | (55.63M) | (105.96M) | (89.83M) | (69.58M) |
| Income Before Tax | 949.36M | 1.07B | 973.73M | 1.04B | 1.05B |
| Pre-Tax Margin | 25.5% | 27.3% | 25.7% | 26.8% | 26.1% |
| Income Tax Expense | 180.38M | 198.09M | 184.95M | 174.08M | 179.72M |
| Net Income | 768.99M | 872.5M | 788.78M | 863.14M | 869.19M |
| Net Margin | 20.7% | 22.3% | 20.8% | 22.3% | 21.6% |
| EPS (Basic) | 33.25 | 38.79 | 36.10 | 40.67 | 42.17 |
| EPS (Diluted) | 32.78 | 38.41 | 35.90 | 40.48 | 42.05 |
| Weighted Avg Shares | 23.13M | 22.49M | 21.85M | 21.22M | 20.61M |
| Weighted Avg Shares (Diluted) | 23.46M | 22.72M | 21.97M | 21.32M | 20.67M |
Mettler-Toledo International Inc.
NYSE:MTD
Intrinsic Alpha fair value
Locked
Current Price
$1,737.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.